skip to content

[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter – full-year earnings outlook raised

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.